Explore the peer-reviewed studies behind trace minerals, fulvic acid, humic substances, mineral transport, gut health, oxidative balance, and other mechanisms that inform the B.E.N. Nutrition philosophy.
The studies referenced below investigate trace minerals, fulvic acid, humic acid, shilajit, and related humic substances, not B.E.N. Minerals specifically.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Human safety & anti-inflammatory trial
This randomized, double-blind, placebo-controlled phase 1 trial in 30 adults evaluated escalating oral doses of a carbohydrate-derived fulvic acid (CHD-FA) solution. Across acute and subacute dosing up to 40 mL of 3.8% CHD-FA twice daily, comprehensive safety labs, ECG, and clinical assessments remained within normal limits, while skin-prick reactivity was significantly reduced. For readers looking for a strong human entry point into the fulvic-acid literature, it is one of the most relevant safety and anti-inflammatory proof-of-concept studies available.
The research in this section explores the body's antioxidant systems that help manage oxidative stress. Trace minerals contribute to normal cellular protection and resilience.
Reviews human and preclinical evidence showing free-radical scavenging activity and protection of antioxidant defenses such as vitamin C, vitamin E, and SOD-related systems. It also ties shilajit-rich fulvic fractions to mitochondrial protection, which is central to oxidative stress resilience.
Read full studyThis review maps several fulvic-acid antioxidant mechanisms, including ROS sequestration and support for GSH, SOD, and CAT activity. It is useful here because it connects redox control to both inflammation and broader metabolic function.
Read full studyDocuments ORAC antioxidant capacity and DPPH activity for shilajit while also cataloging its fulvic-acid-rich mineral composition. It is especially helpful for composition-based support and broad antioxidant context.
Read full studyAlthough centered on hormonal endpoints, this placebo-controlled trial proposes oxidative stress protection as part of the underlying mechanism. It gives human support to the idea that fulvic-rich shilajit acts through mitochondrial and redox pathways.
Read full studyThis 2025 review compiles multiple human studies and repeatedly points back to antioxidant activity as a cross-cutting mechanism. It helps connect redox support with performance, cardiometabolic health, and safety in one current summary source.
Read full studyThis 48-week randomized trial showed significant reductions in MDA and increases in GSH alongside preserved bone mineral density. It gives direct human evidence that shilajit influences oxidative stress biomarkers over a meaningful duration.
Read full studyTrace minerals act as enzyme cofactors involved in energy metabolism. Supports natural cellular energy production and steady day-to-day vitality.
This review cites human data linking shilajit to increased ATP production, higher CoQ10, and mitochondrial protection. It is one of the clearest references supporting an energy-metabolism positioning.
Read full studyCompiles human trial data across fatigue, performance, hormonal health, and broader vitality outcomes. It is useful as a current top-layer review tying multiple human datasets back to energy and physical function.
Read full studyBeyond endocrine endpoints, the authors propose mitochondrial electron-carrier activity and ROS protection as core mechanisms. That makes this trial relevant to cellular energy production, not just hormone output.
Read full studyIn recreationally active men, 500 mg/day of purified shilajit preserved maximal strength after fatiguing exercise versus placebo. It gives practical human support for day-to-day energy and performance resilience.
Read full studyThe studies below examine healthy immune function and a healthy inflammatory response as part of a strong nutritional baseline. Minerals and fulvic compounds help maintain the systems the body relies on every day.
Beyond confirming a favorable short-term safety profile, this double-blind human trial used allergen skin-prick tests to show that CHD-FA significantly reduced wheal-and-flare responses compared with placebo. That pattern is consistent with a controlled, selective immune modulation rather than broad immune stimulation, making it a strong anchor for positioning fulvic compounds around healthy inflammatory balance.
Read full studyDocuments bimodal immune effects and includes human findings on wheal-and-flare reduction comparable to hydrocortisone 1 percent, plus eczema improvement data. It is important because it bridges mechanism and human response.
Read full studyCompiles immune-related findings including macrophage modulation and increased PMN lytic activity. It supports an immune-maintenance framing without forcing a disease-treatment narrative.
Read full studyThis review summarizes immunological findings across multiple clinical papers while also reinforcing the safety window seen in human use. It is a good support source for breadth of evidence.
Read full studyCompiles human clinical data on allergic rhinitis, eczema, and broader humic-substance immune effects. It is especially valuable because it adds actual human immunomodulation outcomes, not just mechanistic discussion.
Read full studyThis section focuses on healthy nervous system signaling and mental performance. Minerals and electrolytes help maintain normal communication between cells.
This is the strongest nervous-system paper in the set because it is a multicenter, double-blind, placebo-controlled human trial. The intervention improved MMSE score, reduced apathy early, and lowered homocysteine without treatment-related adverse events.
Read full studyDirectly tested fulvic-acid-rich fractions for neurite outgrowth and tau aggregation inhibition. It adds mechanistic support that complements the human BrainUp-10 trial above.
Read full studySummarizes reported cholinergic, GABA-mimetic, and parasympathomimetic activity relevant to normal signaling and cognitive support. It functions here as broad neurophysiological context.
Read full studyProvides a current review lens on nootropic and cognitive findings discussed across the shilajit literature. It is useful for showing that the neuro story did not stop with a single paper.
Read full studyThe literature here centers on digestive function and a healthy gut environment. Fulvic compounds support the growth of beneficial gut bacteria, contributing to a balanced microbiome and consistent nutrient absorption.
Describes shifts in microbiota composition, including increased Firmicutes and Lactobacillus with decreases in Proteobacteria. It helps explain why the gut claim can be framed around environment and balance rather than disease endpoints.
Read full studyIncludes anti-ulcerogenic and GI mucosal protection findings that strengthen the digestive-support framing. It is not a microbiome paper, but it broadens the gut-support case.
Read full studyThis prospective human study found about a 30 percent increase in intestinal bacterial concentration after 45 days, with the strongest effect in those starting low. It matters because it is direct human microbiome evidence, even though it uses humic acid rather than fulvic acid specifically.
Read full studyThe research in this section explores how the body absorbs and utilizes key nutrients. Fulvic compounds can support mineral solubility, an important part of everyday nutrient use.
Highlights metal-fulvate complexation and improved cellular penetration of chelated minerals. This is one of the more direct references for a nutrient-use and mineral-bioavailability positioning.
Read full studyDiscusses how fulvic acid can enhance nutrient absorption through enzyme activity and mineral bioavailability. It helps convert the absorption claim from a vague compositional idea into a mechanistic one.
Read full studyCatalogs 85 plus minerals in shilajit and frames fulvic acid as a transport vehicle for minerals and trace elements. It gives broad compositional context that supports the claim architecture.
Read full studyThis human trial is useful as proxy evidence because dose-dependent preservation of bone mineral density implies meaningful mineral retention and utilization over 48 weeks. It is not a direct absorption assay, but it is still one of the strongest human anchors for this area.
Read full studyThe studies below examine naturally occurring electrolytes that support mineral balance, important for daily performance, recovery, and normal nerve and muscle function.
Reinforces the naturally occurring mineral and electrolyte composition of shilajit, including essential trace elements relevant to fluid and nerve-muscle balance. It is composition-led evidence rather than direct hydration testing.
Read full studyThis trial does not measure hydration directly, but it gives indirect human relevance because muscle function and post-fatigue strength depend on adequate mineral status. It fits the current conservative wording better than a harder hydration claim would.
Read full studyThis section focuses on the body's natural detoxification pathways and cellular cleanup processes. Trace minerals help maintain enzymes involved in everyday detox function.
Includes evidence of protection against lead-induced oxidative stress, which supports the idea that humic-rich compounds can help buffer toxic burden. It should still be interpreted as supportive, not as a direct detox treatment claim.
Read full studyThis review documents the chelation of roughly 12 heavy metals, including lead, mercury, cadmium, and arsenic, by humic substances. It is the clearest mechanistic source for the detoxification area on the page.
Read full studyThese studies help explain the broader context behind B.E.N. Minerals: modern soils have lost resilience, and the mineral profile of food has changed over time. Together, they show why eating well does not always guarantee the same nutritional foundation it once did.
Modern agriculture can produce calories at scale while still degrading the soil systems that govern nutrient cycling, biodiversity, and long-term crop quality. These papers show how depletion in the soil moves upstream into food security and downstream into human nutrition.
This paper estimated large global deficits in nitrogen, phosphorus, and potassium across major crop systems, with nutrient shortfalls affecting broad portions of harvested land. It links depleted soils directly to lower yields, weaker soil fertility, and a long-term threat to food security.
Read full studyThis review frames soil degradation as a direct public-health issue, not just an agricultural one. It explains how declining soil structure, biodiversity, and nutrient balance reduce food quality and increase the background risk of malnutrition, especially where local diets depend heavily on local crops.
Read full studyFood can still look abundant while delivering a different mineral profile than it did decades ago. These studies help anchor the claim that part of the nutrition conversation is now about dilution, cultivar changes, and the long arc of industrial agriculture.
This analysis of UK food composition tables across 1940, 1991, and 2019 found broad mineral declines over an 80-year span, including large drops in iron and copper. The authors argue that industrialized agriculture, cultivar shifts, and other agronomic changes likely contributed to the loss in nutrient density.
Read full studyThis widely cited paper compared USDA data for 43 garden crops and found median declines in several nutrients and protein across the second half of the twentieth century. The authors note that not every food declined equally and that part of the pattern may reflect yield-focused breeding that diluted nutrient concentration.
Read full studyThis OECD/GLP toxicology study established a NOAEL of 5,000 mg/kg/day in a 60-day repeated-dose model. It also reported zero toxicity signs and negative genotoxicity assays, making it one of the strongest formal safety anchors in the stack.
Read full studyThis 90-day OECD TG 408/GLP study established a NOAEL of 2,000 mg/kg/day for a fulvic and humic acid preparation. A 28-day recovery period found no residual or delayed effects, reinforcing the absence of cumulative toxicity in the tested model.
Read full studyThis human randomized controlled trial used 500 mg/day for 90 days in healthy volunteers. All safety parameters remained normal throughout the study, with no adverse events reported.
Read full studyThis review summarizes fulvic-acid human tolerability data alongside broader clinical observations on inflammation and metabolic health. It is useful in the safety section because it shows the ingredient class has been evaluated beyond cell models and isolated mechanisms.
Read full studyThis formal Phase 1 study evaluated CHD-FA in 30 healthy volunteers using a randomized, double-blind, placebo-controlled design. No adverse events were reported at any tested dose, including up to 40 mL twice daily.
Read full studyThis mini-review compiles human safety data including fulvic acid at 1.8 g/day and CHD-FA Phase 1 completion without adverse events. It also adds supportive animal safety context for potassium humate, which helps show breadth across related humic substances.
Read full study